Healthy Inc

Mumbai, Maharashtra

GST No. 27AAFFH3493R3ZK

Send Email
0804382784961% Response Rate
Search

Home » Our Products » Levetiracetam Injection


Levetiracetam Injection

Pioneers in the industry, we offer levetiracetam injection and livogrid-500 from India.

Levetiracetam Injection

REQUEST CALLBACK

Levetiracetam Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 110.00 / VialGet Latest Price

Product Details:
Strength100 mg/ml
Vial Volume5 ml
Pack TypeSingle Vial
RouteIV
UsageStatus Epilepticus
Packaging TypeVial
DiluentNS
StorageBelow 25 C
ScheduleSchedule H1

Levetiracetam 500 Mg Inj
LEVETIRACETAM Injection (100 mg / mL)

Healthy Inc offers Levetiracetam Injection, a high-precision SVS (Synaptic Vesicle Protein 2A) ligand antiepileptic. Containing 500 mg of Levetiracetam in a 5 mL vial, this formulation is a clinical priority for the rapid management of seizures when oral administration is not feasible. As a specialized Indian export partner, we supply this advanced neurological asset to neurology departments and intensive care units globally from our Mumbai export hub.

  • Novel Mechanism of Action: Unlike traditional antiepileptics that target sodium or calcium channels, Levetiracetam binds to the Synaptic Vesicle Protein 2A (SV2A). This unique binding modulates neurotransmitter release, providing potent seizure control with a superior safety profile and minimal drug-drug interactions.

  • Clinical Criticality: Indicated for the treatment of Partial Onset Seizures, Myoclonic Seizures, and Primary Generalized Tonic-Clonic Seizures. It is an essential alternative in the management of Status Epilepticus due to its rapid onset and lower risk of respiratory depression compared to benzodiazepines or barbiturates.

  • Pharmacokinetic Advantage: Levetiracetam exhibits linear pharmacokinetics and is primarily excreted unchanged by the kidneys. This makes it a preferred choice for patients with liver impairment and significantly reduces the complexity of therapeutic drug monitoring.

  • Manufacturing Excellence: Produced in associated WHO-GMP certified sterile facilities. The solution is formulated with precise osmotic balancing (Sodium Chloride/Sodium Acetate) to ensure high stability and patient safety during Intravenous (IV) Infusion.

B2B Technical Specifications
Feature Specification
Active Ingredient Levetiracetam
Strength 100 mg / mL (500 mg in 5 mL)
Therapeutic Class Antiepileptic / Anticonvulsant
Regulatory Status WHO-GMP Certified Production
Primary Packaging USP Type I Glass Vial
Route of Admin. Intravenous (IV) Infusion (Must be diluted)
Storage Store below 30°C; Do not freeze
Logistics & Export Optimization

As a pharmacist-led organization, we recognize that neurological agents require uncompromising purity. We utilize USP Type I glass vials and specialized secondary packaging to protect the product from physical shock and light during multi-modal international transit. Our logistics team ensures that shipments to Africa, LATAM, and SEA are handled with climate-controlled protocols to prevent molecular degradation in high-temperature Zone IVb environments.

Yes! I am Interested

LIVOGRID-500

REQUEST CALLBACK

LIVOGRID-500
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 122.90 / VialGet Latest Price

Product Details:
Strength100 mg/ml
Vial Volume5 ml
Pack TypeSingle Vial
RouteIV
UsageStatus Epilepticus
Packaging TypeVial
DiluentNS
StorageBelow 25 C
ScheduleSchedule H1

Each 5 Ml Contains: Levetiracetam I.P. 500 Mg + Water For Injection I.P. Q.s.
LIVOGRID-500 Injection (Levofloxacin Infusion IP 500 mg / 100 ml)

Healthy Inc offers LIVOGRID-500, a high-potency Third-Generation Fluoroquinolone Antibiotic. Containing Levofloxacin, LIVOGRID-500 provides broad-spectrum bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens, including Streptococcus pneumoniae and Haemophilus influenzae. It is a clinical priority for the treatment of Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia, Acute Pyelonephritis, and Complicated Urinary Tract Infections (cUTI). As a specialized Indian export partner, we supply this essential anti-infective to respiratory clinics and general hospital networks in global pharmaceutical markets.

  • Bactericidal Efficiency: Works by inhibiting bacterial DNA gyrase and topoisomerase IV, effectively preventing DNA replication and cell division.

  • Manufacturing: Produced in associated WHO-GMP certified sterile facilities specialized in Large Volume Parenterals (LVP), ensuring 100% sterility, high molecular purity, and precise 5 mg/ml concentration in a 100 ml infusion.

  • Climate Stability: Validated for Zone IVb (Hot/Humid) conditions, ensuring the chemical integrity and antimicrobial potency of the molecule across Africa, LATAM, and SEA markets.

  • Regulatory Support: Full technical documentation available, including CTD/eCTD Dossiers, to streamline the registration of essential hospital-grade antibiotics.

Accepting B2B inquiries for contract manufacturing, bulk supply, and global distribution partnerships from our Mumbai export hub.

Available strengths and packaging? We supply LIVOGRID-500 in 100 ml presentations (containing 500 mg Levofloxacin). It is available in high-quality Non-PVC / Self-Collapsible Bags or USP Type I glass bottles. Every batch undergoes rigorous HPLC-based assay testing and sterility validation.

Support for tropical export? Yes. LIVOGRID-500 is Zone IVb stability-tested. We utilize light-protected secondary packaging and specialized export-grade outer cartons to ensure product integrity during international transit to high-temperature regions.

Registration assistance provided? We provide complete Regulatory Technical Files (CTD) and Certificates of Analysis (COA) to facilitate local health authority approvals and government hospital tender participations in your specific territory.

Small-volume or mixed orders? We specialize in mixed-container consolidation, allowing you to combine LIVOGRID-500 with other critical care infusions (such as Linezolid, Metronidazole, or Ciprofloxacin) in a single, cost-effective shipment.

Direct sourcing? Products are sourced through Healthy Life Group’s associated WHO-GMP manufacturing units, ensuring competitive direct-from-factory pricing and strict quality control oversight for essential anti-infective therapies.

Yes! I am Interested

X


Explore More Products

Contact via E-mail
Contact via SMS
Mr. Nishith Shah (CEO)
Healthy Inc
2, Office No. 2b-I, Citi Mall, Building No. 03, Link Road, Andheri West
Mumbai - 400053, Maharashtra, India
Call Us: 
Call Response Rate: 61%
Share Us :



Home  |   Profile   |  Our Products  |  Site Map  |   Contact Us

© Healthy Inc. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Healthy Inc